Detail page

Knowledge Web

Person

Sabine Kayser (1979-)

Ärztin

Name	Sabine Kayser
Time	1979- (Date of birth and death)
Place	Göppingen (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Academic degree	Dr.
Profession	Ärztin (characteristic profession)
Related	Universität Heidelberg. Klinikum (2014-2020)
Further information	Diss. Medizinische Fakultät an der Universität Ulm; Fachärztin für Innere Medizin, Schwerpunkt Hämatologie und Internistische Onkologie, Innere Medizin V, Medizinische Klinik, Universitätsklinikum Heidelberg; Jetzt: Oberärztin bei Institut für Transfusionsmedizin und Immunologie Mannheim
Record type	Person
GND-Identifier	138694923
Record ID	138694923
Involved in show all Randomized comparison of cardiotoxicity with 60 versus 90 mg daunorubicin in AML induction therapy Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study Prolonged Thrombocytopenia and Severe Transfusion Reaction after ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Myelomonocytic Leukemia Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors Atypical presentation of patients with chronic myeloid leukemia in chronic phase : Case report Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML Management of patients with acute promyelocytic leukemia Molekularzytogenetische Analyse zum Nachweis rekurrenter Chromosomenaberrationen bei der akuten myeloischen Leukämie des älteren (>60 Jahre) Patienten mit Hilfe der Fluoreszenz-in-situ-Hybridisierung (FISH) unter Berücksichtigung der diagnostischen Wertigkeit

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Sabine Kayser (1979-)

Randomized comparison of cardiotoxicity with 60 versus 90 mg daunorubicin in AML induction therapy

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study

Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study

Prolonged Thrombocytopenia and Severe Transfusion Reaction after ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Myelomonocytic Leukemia

Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors

Atypical presentation of patients with chronic myeloid leukemia in chronic phase : Case report

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4

Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study

Management of patients with acute promyelocytic leukemia

Molekularzytogenetische Analyse zum Nachweis rekurrenter Chromosomenaberrationen bei der akuten myeloischen Leukämie des älteren (>60 Jahre) Patienten mit Hilfe der Fluoreszenz-in-situ-Hybridisierung (FISH) unter Berücksichtigung der diagnostischen Wertigkeit